Amunix Pharmaceuticals
Latest round
- Series B
Last raised
- Feb 2021
Total raised
- $201M
Investors
- 18
About Amunix Pharmaceuticals
Founded in 2006 and based in California, US, Amunix Pharmaceuticals, Inc. operates as a biopharmaceutical company. The company was founded by Volker Schellenberger. Amunix is a biopharmaceutical company that focuses on developing masked, protease-activated immune-oncology therapeutics to bring the promise of these potent therapies to patients with solid tumor cancers. Amunix offers XPAT® and XPAC™ technology platforms to develop novel drugs that are preferentially activated in the tumor microenvironment and designed to overcome toxicity challenges that have hindered other T cell and cytokine therapies. Amunix's pipeline includes AMX-818, an XPAT® T cell engager targeting a variety of HER2-expressing solid tumors, which is currently in IND-enabling studies. Along with several other T cell engager programs, the company is also applying its proprietary masking technology to its first masked, protease-activated cytokine program, IL12-XPAC™, which is in the discovery stage. The company plans to continue developing AMX-818, a masked, protease-activated T cell engager (XPAT®) targeting HER2-expressing solid tumors, as well as support Amunix’s pipeline of earlier-stage XPATs® and masked, protease-activated cytokines (XPACs™).
Who invested in Amunix Pharmaceuticals
18 investors across 2 rounds
See all investors in Amunix Pharmaceuticals
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Amunix Pharmaceuticals
Who invested in Amunix Pharmaceuticals?
Amunix Pharmaceuticals has 18 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Amunix Pharmaceuticals raised?
Amunix Pharmaceuticals has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Amunix Pharmaceuticals last raise money?
Amunix Pharmaceuticals's most recent round on record is a Series B, in Feb 2021.
What does Amunix Pharmaceuticals do?
Founded in 2006 and based in California, US, Amunix Pharmaceuticals, Inc.
Where is Amunix Pharmaceuticals headquartered?
Amunix Pharmaceuticals is headquartered in San Francisco, US.
Which VCs invest in companies like Amunix Pharmaceuticals?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Amunix Pharmaceuticals's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Amunix Pharmaceuticals? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.